BGB-3111-306
Active, not recruiting
A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
BeOne Study ID 
BGB-3111-306
ClinicalTrials.gov ID
EudraCT Number
2023-509908-15-00
China Drug Trials ID
CTR20211594
Study Overview
Sex:
All
Age: 60 Years / N/A
No Study Documents
Study Overview
Sex:
All
Age: 60 Years / N/A
No Study Documents